Epidermal growth factor receptor in non-small-cell lung carcinomas: correlation between gene copy number and protein expression and impact on prognosis.
about
Clinical relevance of neutral endopeptidase (NEP/CD10) in melanomaIdentification of novel candidate target genes, including EPHB3, MASP1 and SST at 3q26.2-q29 in squamous cell carcinoma of the lungEGFR phosphorylates and inhibits lung tumor suppressor GPRC5A in lung cancerLyn, a Src family kinase, regulates activation of epidermal growth factor receptors in lung adenocarcinoma cellsEGF receptor gene mutations are common in lung cancers from "never smokers" and are associated with sensitivity of tumors to gefitinib and erlotinibTrials to Overcome Drug Resistance to EGFR and ALK Targeted Therapies - Past, Present, and FutureMolecular biology of lung cancer: clinical implicationsEGFR targeted therapy in non-small cell lung cancer: potential role of cetuximabEpidermal growth factor receptor tyrosine kinase inhibitors for the treatment of non-small-cell lung cancer: results and open issuesFibroblast growth factor (FGF) and FGF receptor-mediated autocrine signaling in non-small-cell lung cancer cellsMucinous differentiation correlates with absence of EGFR mutation and presence of KRAS mutation in lung adenocarcinomas with bronchioloalveolar featuresBiological response modifiers in cancerTransformation of human bronchial epithelial cells alters responsiveness to inflammatory cytokines.Spotlight on afatinib and its potential in the treatment of squamous cell lung cancer: the evidence so farAdvances of hypoxia and lung cancerEGFR gene copy number as a prognostic marker in colorectal cancer patients treated with cetuximab or panitumumab: a systematic review and meta analysisAt the crossroads: EGFR and PTHrP signaling in cancer-mediated diseases of boneEGFR Overexpressed in Colonic Neoplasia Can be Detected on Wide-Field Endoscopic Imaging.Molecular pathology of lung cancer: key to personalized medicine.EGFR gene copy number as a predictive biomarker for patients receiving tyrosine kinase inhibitor treatment: a systematic review and meta-analysis in non-small-cell lung cancer.EGFR exon-level biomarkers of the response to bevacizumab/erlotinib in non-small cell lung cancerLow EGFR/MET ratio is associated with resistance to EGFR inhibitors in non-small cell lung cancer.Clinical potential of necitumumab in non-small cell lung carcinomaEpidermal growth factor receptor immunohistochemistry: new opportunities in metastatic colorectal cancerNovel insights into the molecular origins and treatment of lung cancerGene expression-based classification of non-small cell lung carcinomas and survival predictionEGFR tyrosine kinase inhibitors activate autophagy as a cytoprotective response in human lung cancer cellsModeling of tumor progression in NSCLC and intrinsic resistance to TKI in loss of PTEN expressionQSAR-based models for designing quinazoline/imidazothiazoles/pyrazolopyrimidines based inhibitors against wild and mutant EGFRProgesterone receptor (PR) polyproline domain (PPD) mediates inhibition of epidermal growth factor receptor (EGFR) signaling in non-small cell lung cancer cells.In vivo photoacoustic tomography of EGFR overexpressed in hepatocellular carcinoma mouse xenograft.Enhanced Therapeutic Epidermal Growth Factor Receptor (EGFR) Antibody Delivery via Pulsed Ultrasound with Targeting Microbubbles for Glioma TreatmentPrognostic and predictive value of epidermal growth factor receptor tyrosine kinase domain mutation status and gene copy number for adjuvant chemotherapy in non-small cell lung cancer.Visualizing epithelial expression of EGFR in vivo with distal scanning side-viewing confocal endomicroscope.Coiled-coil domain containing 68 (CCDC68) demonstrates a tumor-suppressive role in pancreatic ductal adenocarcinoma.EGFR soluble isoforms and their transcripts are expressed in meningiomas.Copy number amplification of the PIK3CA gene is associated with poor prognosis in non-lymph node metastatic head and neck squamous cell carcinoma.Coexpression of epidermal growth factor receptor with related factors is associated with a poor prognosis in non-small-cell lung cancer.Affibody molecules: potential for in vivo imaging of molecular targets for cancer therapy.Epidermal growth factor receptor (EGFR) gene copy number detection in non-small-cell lung cancer; a comparison of fluorescence in situ hybridization and chromogenic in situ hybridization.
P2860
Q21093253-CC27FFE5-002A-4BFA-9B26-05154CB0211EQ21260385-429720FF-E12A-4ACC-B83F-863B0215055AQ24305519-97DE6BB2-1E6C-4DDD-B5D8-E1B6364B0131Q24309725-AA1B8925-945D-41F7-9E22-C3C7C8A935F4Q24561953-D1C20ACA-5D44-4F01-ADBB-E23CADAEA664Q24564024-5FF24B50-FE5F-4F92-BB0E-3B5B5C64477DQ24610335-55F9FC9B-538F-4BE8-A843-EB976D6E204EQ24652337-64B7642F-9DBE-422A-9CE7-00BBB9ACA5A2Q24653036-AB87308A-7524-4173-A252-9CD05755A622Q24658237-A685E14B-7753-4413-A656-33503B66E8B2Q24683814-4D09CC5B-79D1-4792-9783-2CC22AB5B44AQ24685049-7D7C47AB-851A-4285-9B51-3D78EBBF76C3Q24811363-3BAE53C4-27F1-4EB4-B644-5065F09900A5Q26745776-83872DD9-225B-476F-A53B-BA2896BF863FQ26860343-91D0250B-6F4C-402A-8AB7-2A7499ACD384Q26865056-7526D9D2-9096-4E80-9331-C45F2FDFF5DCQ26866067-45EF9CFB-3E23-4E28-B82B-F8F0AE239B13Q27325591-ABFF0C88-2BD1-4088-A489-D312D7F4BE08Q27691299-F9CF9DD8-2085-414B-8232-29F231FCFA04Q27851583-8F4C8D7C-6733-4E28-B4FC-1282BFCEDD39Q27852543-94216FE1-C20B-487C-86B3-1FEDF6723E44Q27853221-823143C4-FF12-45A5-B5F6-0A8DBB892481Q28072850-A33BDE6B-4205-4574-9FE1-F3182B63C73BQ28084216-361494AE-2396-4636-90BE-4478DE2FE68BQ28386773-4771B32F-F98E-4387-A05E-F063D84697BAQ28395058-DCD5F56A-579C-49E2-B6C4-23A704A3D792Q28478401-98D35D3E-1A7B-45CB-A3CB-C1CEAD9A10CEQ28484612-F80F0568-3A24-422A-950E-058B743D90A4Q28540324-2BF35E7C-24E9-439D-90B7-1A0435B1C918Q30009019-997E4004-3793-44A7-8436-01F8933A0D65Q30372076-C4E6904D-F8B4-45EF-828C-E6F221C666E3Q30412519-40D0001E-48AF-4DE3-A148-013D7CDB66F8Q30498101-E624809A-9555-4A7B-80F6-C77BE24C1F5EQ30829381-06CA7A8C-EC63-44C0-A424-29C9FB2E643CQ30831639-17CB1F5E-65CB-481B-AD1C-C6A6C30ECB1CQ31062214-5E1ECBE3-AF92-432E-B552-4675B6AFE0A2Q31096247-FE1291B8-0D7C-450D-BE75-7867533916D2Q33206782-66739C79-6A62-4ACD-A739-03454D048FFEQ33279445-077F3EF0-6CCE-4387-81D8-20E5CEA92167Q33302191-0D5A002F-0720-4F89-8D3D-4E3A25DB1019
P2860
Epidermal growth factor receptor in non-small-cell lung carcinomas: correlation between gene copy number and protein expression and impact on prognosis.
description
2003 nî lūn-bûn
@nan
2003 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Epidermal growth factor recept ...... ssion and impact on prognosis.
@ast
Epidermal growth factor recept ...... ssion and impact on prognosis.
@en
Epidermal growth factor recept ...... ssion and impact on prognosis.
@nl
type
label
Epidermal growth factor recept ...... ssion and impact on prognosis.
@ast
Epidermal growth factor recept ...... ssion and impact on prognosis.
@en
Epidermal growth factor recept ...... ssion and impact on prognosis.
@nl
prefLabel
Epidermal growth factor recept ...... ssion and impact on prognosis.
@ast
Epidermal growth factor recept ...... ssion and impact on prognosis.
@en
Epidermal growth factor recept ...... ssion and impact on prognosis.
@nl
P2093
P356
P1476
Epidermal growth factor recept ...... ession and impact on prognosis
@en
P2093
Anna E Barón
Fred R Hirsch
Marileila Varella-Garcia
Paul A Bunn
Robert Veve
Roy M Bremmes
Wilbur A Franklin
P304
P356
10.1200/JCO.2003.11.069
P407
P577
2003-09-02T00:00:00Z